Abstract
Alzheimer’s disease (AD) is one of the most prevalent disorders which can mainly occur due to the imbalance of acetylcholinesterase enzyme in the brain. Acetylcholinesterase is an enzyme responsible for the hydrolysis and subsequently, deficiency of the neurotransmitter, acetylcholine (Ach.) in the AD. Seeking for medicinal compounds with the ability to inhibit the regarding enzyme is one of the main targets in the management of AD. Generally, efficiency and therapeutic effects of medicaments with the underlying mechanism of enzyme inhibition are evaluated and determined via a value, called IC50 (the concentration, in which 50% of inhibition would be achieved). In this study, via the employment of the data envelopment analysis (DEA) method, the ranking model is used to determine the most desirable agent among 16 medicinally-synthetic compounds with 626 descriptors. All of those medicaments possessed inhibitory activities against the acetylcholinesterase enzyme. Herein, we considered each synthetic medicament as decision-making units, and the descriptors as inputs and outputs parameters of the DEA models. Via the DEA method, selected synthetic compounds have been ranked to determine the best agents. The outcomes have been compared with the in vitro results.
Similar content being viewed by others
References
Andersen P, Petersen NC (1993) A procedure for ranking efficient units in data envelopment analysis. Manag Sci 39:1261–1264
Bagheri M, Ebrahimnejad A, Razavyan S, Hosseinzadeh Lotfi F, Malekmohammadi N (2020a) Fuzzy arithmetic DEA approach for fuzzy multi-objective transportation problem. Oper Res.https://doi.org/10.1007/s12351-020-00592-4
Bagheri M, Ebrahimnejad A, Razavyan S, Hosseinzadeh Lotfi F, Malekmohammadi N (2020b) Solving the fully fuzzy multi-objective transportation problem based on the common set of weights in DEA. J Intell Fuzzy Syst 39(3):3099–3124. https://doi.org/10.1007/s12351-020-00592-4
Banker RD, Charnes A, Cooper WW (1984) Some models for estimating technical and scale inefficiencies in data envelopment analysis. Manag Sci 30:1078–1092
Charnes A, Cooper WW, Rhodes E (1978) Measuring the efficiency of decision making units. Eur J Oper Res 2:429–444
Cummings JL, Morstorf T, Zhong K (2014) Alzheimer’s disease drug-development pipeline: few candidates, frequent failures. Alzheimer’s Res Ther 6(37):1–7
Cook WD, Zhu J (2007) Classifying inputs and outputs in data envelopment analysis. Eur J Oper Res 180:692–699
Despić O, Despić M, Paradi JC (2007) DEA-R: ratio-based comparative efficiency model, its mathematical relation to DEA and its use in applications. J Prod Anal 28:33–44
Ebrahimnejad A, Hosseinzadeh Lotfi F (2012) Equivalence relationship between the general combined-oriented CCR model and the weighted minimax MOLP formulation. J King Saud Univ Sci 24(1):47–54
Ebrahimnejad A, Tavana M, Manosourzadeh SM (2015) An interactive MOLP method for solving output-oriented DEA problems with undesirable factors. J Ind Manag Optim 11(4):1089–1110
Ebrahimnejad A, Tavana M (2014) An interactive MOLP method for identifying target units in output-oriented DEA models: The NATO enlargement problem. Measurement 52:124–134
Ebrahimnejad A, Tavana M, Hosseinzadeh Lotfi F, Shahverdi M, Yousefpour M (2014) A three-stage data envelopment analysis model with application to banking industry. Measurement 49:308–319
Ebrahimnejad A, Amani N (2021) Fuzzy data envelopment analysis in the presence of undesirable outputs with ideal points. Complex Intell Syst 7:379–400
Emrouznejad A, Yang G-lJS-EPS (2018) A survey and analysis of the first 40 years of scholarly literature in DEA: 1978–2016. Socioecon Plan Sci 61:4–8
Fassihi A, Sabet R (2008) QSAR Study of p56lck protein tyrosine kinase inhibitory activity of flavonoid derivatives using MLR and GA-PLS. Int J Mol Sci 9:1876–1892
Ferreira MMC, Montanari CA, Gaudio ACJQN (2002) Seleção de variáveis em QSAR. Quim Nova 25:439–448
Francis PT (2005) The interplay of neurotransmitters in Alzheimer’s disease. CNS Spectr 10(S18):6–9
Garcia-Alloza M, Zaldua N, Diez-Ariza M, Marcos B, Lasheras B, Javier Gil-Bea F et al (2006) Effect of selective cholinergic denervation on the serotonergic system: implications for learning and memory. J Neuropathol Exp Neurol 65(11):1074–1081
Heinrich M, Teoh HL (2004) Galanthamine from snowdrop—the development of a modern drug against Alzheimer’s disease from local Caucasian knowledge. J Ethnopharmacol 92(2–3):147–162
Hemmateenejad B, Miri R, Akhond M, Shamsipur MJAdPAIJP, Chemistry M (2002a) Quantitative structure-activity relationship study of recently synthesized 1,4-dihydropyridine calcium channel antagonists. Appl Hansch Anal Method Archiv Der Pharmazie Brian Fulton 335:472–480
Hemmateenejad B, Miri R, Akhond M, Shamsipur MJC (2002) QSAR study of the calcium channel antagonist activity of some recently synthesized dihydropyridine derivatives. An application of genetic algorithm for variable selection in MLR and PLS methods. Chemom Intell Lab Syst 91:64–99
Kachouei M, Ebrahimnejad A, Bagherzadeh-Valami H (2020) A common-weights approach for efficiency evaluation in fuzzy data envelopment analysis with undesirable outputs: Application in banking industry. J Intell Fuzzy Syst 39(5):7705–7722
Katritzky AR, Kuanar M, Slavov S, Hall CD, Karelson M, Kahn I, Dobchev D (2010) Quantitative correlation of physical and chemical properties with chemical structure: utility for prediction. Chem Rev 110:5714–5789
Lahiri DK, Farlow MR, Greig NH, Sambamurti K (2002) Current drug targets for Alzheimer’s disease treatment. Drug Dev Res 56:267–281
Mehrabian S, Alirezaee MR, Jahanshahloo GR (1999) A complete efficiency ranking of decision making units in data envelopment analysis. Comput Optim Appl 14:261–266
Najar AV, Pooya A, Zoeram AA, Emrouznejad A (2018) Assessing the relative performance of nurses using data envelopment analysis matrix (DEAM). J Med Syst 42:125
Riazimontazer E, Sadeghpour H, Nadri H, Sakhteman A, Küçükkılınç TT, Miri R, Edraki N (2019) Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives. Bioorg Chem 89:103006
Soleimani-Damaneh M, Zarepisheh M (2009) Shannon’s entropy for combining the efficiency results of different DEA models: method and application. Expert Syst Appl 36:5146–5150
Wei C-K, Chen L-C, LiTsai C-HJESwA, R-K (2011) Exploration of efficiency underestimation of CCR model: based on medical sectors with DEA-R model. Expert Syst Appl 38:3155–3160
Wei C-K, Chen L-C, Li R-K, Tsai C-H, Huang H-L (2012) A study of optimal weights of data envelopment analysis-development of a context-dependent DEA-R model. Expert Syst Appl 39:4599–4608
Acknowledgements
The authors would like to thank the anonymous reviewers and the associate editor for their insightful comments and suggestions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tabatabaei, S., Mozaffari, M.R., Rostamy-Malkhalifeh, M. et al. Using DEA Models for Ranking Compounds as Acetylcholinesterase Inhibitors in the Management of Alzheimer's. Iran J Sci Technol Trans Sci 46, 189–202 (2022). https://doi.org/10.1007/s40995-021-01207-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40995-021-01207-z